1 unchanged sentence
Market Information
−Removed: Our Common Shares are traded on the Nasdaq Stock Market under the symbol “AIRS.”
−Removed: We have not and do not currently intend to, pay any dividends on our common stock.
−Removed: Any determination to pay dividends to holders of our common stock will be at the discretion of our board of directors and will depend on many factors, including our financial condition, results of operations, projections, liquidity, earnings, legal requirements, restrictions in the agreements governing any indebtedness we may enter into and other factors that our board of directors deems relevant.
+Added: Our Common Shares are traded on the Nasdaq Global Market under the symbol “AIRS.”
+Added: During the twelve months ended December 31, 2022, we paid a $23.2 million dividend on our common stock.
+Added: We currently intend to retain all available funds and future earnings and do not anticipate declaring or paying any cash dividends in the foreseeable future.
+Added: Any determination to pay future dividends to holders of our common stock will be at the discretion of our board of directors and will depend on many factors, including our financial condition, results of operations, projections, liquidity, earnings, legal requirements, restrictions in the agreements governing any indebtedness we may enter into and other factors that our board of directors deems relevant.
Holders of Record
4 unchanged sentences
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters—Equity Compensation Plan Information”, incorporated herein by reference.
−Removed: Use of Proceeds
−Removed: On October 28, 2021, our Registration Statement on Form S-1, as amended (Reg.
−Removed: 333-260067), was declared effective by the SEC in connection with our IPO pursuant to which we and selling stockholders registered and sold an aggregate of 8,050,000 shares of our common stock (including 1,050,000 shares sold pursuant to the underwriters' option to purchase additional shares) at a price of $11.00 per share.
−Removed: Morgan Stanley & Co.
−Removed: LLC, Piper Sandler & Co., and SVB Leerink LLC acted as representatives in the offering.
−Removed: The offering commenced on October 28, 2021 and closed on November 2, 2021, resulting in net proceeds to us of $13.5 million after deducting underwriters' discounts and commissions.
−Removed: The net proceeds to us from the IPO were used to fund our growth strategy of opening new de novo facilities and adding procedure rooms to existing facilities.
−Removed: There has been no material change in the planned use of proceeds from our IPO as described in the section titled “Use of Proceeds” in the prospectus.
This item has been removed and reserved pursuant to SEC order.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.